Results 231 to 240 of about 492,253 (263)

Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment

Cancer Cell, 2017
Costas Koumenis, Priya Chatterji, J Alan   +2 more
exaly  

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Lancet, The, 1998
Thierry Poynard, Vincent Bain, Gaetano Ideo   +2 more
exaly  

THE INTERFERONS

British Medical Bulletin, 1985
openaire   +2 more sources

INTERFERONS

2006
J.N. Kline, K. Kitagaki
openaire   +1 more source

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)

Lancet, The, 2002
Angelo Ghezzi, Mauro Bergui, Luca Durelli   +2 more
exaly  

Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

Lancet, The, 1998
Anders Sönnerborg, Ola Weiland, Olle Reichard   +2 more
exaly  

Interferons

New England Journal of Medicine, 1962
openaire   +2 more sources

Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.

Journal of Experimental Medicine, 1984
Robert Schreiber
exaly  

INTERFERON

Nutrition Reviews, 2009
openaire   +2 more sources

Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis

Lancet, The, 1998
Ludwig Kappos
exaly